Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anyone watching INSM today? They've had two stays on their trial so far and there's lots of speculation that they are in negotiations with TRCA and DNA for a settlement. The chart looks really nice. Holding its gain so far today- if it closes near 1.60 i'll be in.
OK, so I'm going to buy 30000000 shares today. How the heck am I ever going to unload those when that's 3x as much as the stock usually trades. I guess if you have $200 in it you might make a few $ but I just can't understand how you get so excited about it.
Right...so who's going to make a lot of money on this stock if most days it trades under $3000 worth of volume. What's the float- maybe I'll just buy the whole company...
CTTJ has $4000 worth of volume today...how much interest can you really have in this stock????
ALRY- anyone here in this? I noticed CLYP on the ask, does he play a big part in this stock? Thanks
Why is KENT running? No news on alphatrade???
wow- not one green stock in the NYSE top 50 volume actives...
Wow- so far so boring trading-wise today. My first day off in a month and a half to trade and nothing good :( Does anyone know anything about COGC? Looked liked it was going to break .75 and make the chart look really nice but it's down now. Has a really good CEO evidently and has taken a lot of companies up big time price wise. Anyone in this?
Anyone here use Stockfetcher.com? Really good stock screener site for under $10 a month. It's been really helpful to me. FWIW
Some basic HTI DD for you guys-
Halozyme Therapeutics has two most promising drugs right now, HYLENEX and ENHANZE ( There's a brief description of both at the end of this post). A few important points...
- Most importantly for us traders, CHECK OUT THE CHART!!! After yesterday the chart is beautiful and looks primed for good pop in the short term into the teens.
- HTI entered into an Agreement worth over $111 million with ROCHE PHARM (the largest Pharm company in Europe) for the application of ENHANZE.
-Two days ago HTI expanded its relationship with BAXTER PHARM to the tune of $65 million+.
-Around 60% of the AS is owned by insiders and Institutions with more buying everyday. For those who know about Kirk Randall, he bought in big time two months ago.
"HYLENEX recombinant is a liquid injectable formulation that includes the active pharmaceutical ingredient, recombinant human hyaluronidase (rHuPH20), which is approved by the U.S. Food and Drug Administration (FDA) for use as a spreading agent to increase the absorption and dispersion of other injected drugs and for subcutaneous (SC) hydration."
"Enhanze Technology is Halozyme's proprietary drug delivery technology based on recombinant human hyaluronidase (rHuPH20), a recombinant form of the naturally occurring human enzyme approved by FDA for its ability to break down hyaluronic acid (HA), the space-filling "gel"-like substance that is a major component of tissues throughout the body. When combined or co-formulated with certain injectable drugs, Enhanze Technology can act as a "molecular machete" to facilitate the penetration and dispersion of these drugs by temporarily opening flow channels under the skin."
HTI- new HOD and almost back at yesterday's all time high. Please check out this smokin' chart. News with Baxter Pharm yesterday and also good phase III trial results. This stock is ready to rock to the teens
Hey- BB, What do you think about HTI and its chart? Am I crazy for liking this chart so much? Been in since 7.20...Thanks!
HTI- more news today with Baxter. Gee, I hope you guys have been following this stock- new all time high today.
I'm loving the HTI chart- it's giving me goosebumps! Hope you guys have this on your radar!
HTI testing all time high- wait for a dip if you're going to get in- I think this just a technical move to retest high. Should dip and consolidate again for the real big move.
Friends- please check out HTI. This Amex Pharm is ready to pop big time. The chart is phenominal- I've been holding for a month and I think the next week or two is goin to be incredible. Do the DD- you'll be flabbergasted!
Good luck to you with KMDO if you really believe in it. I'm just really skeptical of people falling in love with pennies too much and then pumping them. I just play 'em and leave 'em. Most pennies are little caterpillars in the middle of a herd of elephants. Be careful. We got married in Sept, I'm loving it so far- thanks and good luck!
Does KMDO really have anything that IBM, Norton or any of the other $ Billion companies don't have? If they do, they should have some pretty huge customers by now. I highly doubt it....
C'mon- do you really think MGMX looks good??? Too bad we can't keep this board clean for real picks. MGMX will be .0001X.0002 very soon. Same kind of thing as PDSC and many others. I know this is a penny board but really, c'mon......
GM all- some positive thoughts here...
32 Reasons Stocks Will Jump This Year
Thursday February 1, 12:45 pm ET
ByGary Douglas Smith, Street Insight Contributor
Last year around this time, I speculated on the 20 reasons U.S. stocks would rise a total of 15% for the year. This year, I have 32 reasons for a 17% total return in the S&P 500 for the year. I believe:
1. U.S. GDP growth will average 3.0% this year. My reasons: Housing- and auto-related weakness will subside, and the GDP deflator will subtract less from nominal growth as inflation continues to decelerate.
2. Americans' median household net worth will hit another all-time high. This will be due to home values remaining near record highs after a historic run-up, stock portfolios continuing to rise, wages continuing to outpace inflation and unemployment remaining low.
3. Consumer spending will accelerate back to above-average rates. The catalysts include more seasonally appropriate weather, a healthy job market, wages substantially outpacing inflation, rising stocks, a stabilizing housing market, pent-up demand, lower energy prices and rising confidence.
4. Housing sales are likely to improve modestly. This will lead to a dramatic decline in home inventories as new construction remains muted throughout the year. The average home price is likely to trend slightly lower through the first two quarters of the year, before a modest uptick into year-end leaves prices about even.
5. The unemployment rate will average 4.5% throughout the year. It has averaged a very low 4.6% over the last 12 months and has been lower than that during only two other periods since the mid-1950s. More technology, health care and financial jobs will help offset real estate-related job losses.
6. Americans' average hourly earnings will continue to rise well above the rate of inflation as measured by the consumer price index. U.S. AHE rose 4.2% year over year in December, substantially above the 3.2% year-over-year average for the last 20 years. Throughout the 1990s' economic expansion, AHE exceeded current annual rates of 4.2% during only four months.
7. Measures of inflation will continue to decelerate throughout most of the year, as commodities decline and global growth decelerates from current levels, with CPI averaging around 2.0%. This would be meaningfully below the 20-year average annual rise in CPI of 3.1%. The CPI rose 1.3%, 2.0% and 2.5% year over year during the last three months of the year. The CPI has been lower than current rates during only four other periods since the mid-1960s.
8. Consumers' irrational pessimism will lift. I'll go so far as to say that both main gauges -- the Conference Board's measure and the University of Michigan's Consumer Sentiment Survey -- of their sentiment will make new cycle highs, moving to levels normally associated with healthy economic expansions. While overall U.S. public sentiment is still depressed given the macro backdrop, I see some signs that pessimism is lifting a bit (anecdotal evidence and subindices of the confidence readings). This should make the many bears very nervous, because keeping the public excessively pessimistic on U.S. stocks has been one of their main weapons.
9. The 10-year yield will average 4.75% for the year as economic growth comes in around average levels, inflation decelerates further, the U.S. dollar remains stable to higher and international investors' demand for U.S. Treasuries remains strong.
10. The Federal Reserve will leave the fed funds target rate at 5.25% while making both hawkish and dovish comments throughout the year, depending on current market perceptions. I don't believe a move is coming, but I do believe a cut is more likely than a hike.
11. The U.S. dollar index will remain stable to higher. I see it trading in a range of 80.0 to 93.0 as the U.S. budget deficit continues to improve, U.S. economic growth improves relative to global economic growth, cracks in the euro develop and international demand for U.S. assets rises.
12. The U.S. budget deficit, which is currently 1.5% of GDP, well below the 40-year average of 2.3% of GDP, will continue to trend lower as healthy economic activity continues to boost tax receipts substantially more than estimates.
13. Corporate spending will rise more than expected. Companies flush with cash will gain confidence in the sustainability of the current expansion and spend on productivity-enhancing technologies.
14. S&P 500 earnings will rise about 8.0% for the year, still slightly above the long-term average of 7%. The most-cyclical companies will see a meaningful deceleration in growth, which will more than offset acceleration in other areas.
15. The mania for commodities will completely end. We'll even recognize a bear market in the sector as the CRB Index falls another 10% to 15% for the year. The end of the commodity mania will be viewed as the "pin that pricked the U.S. negativity bubble."
16. Oil falls to $35 to $40 per barrel as the extreme euphoria surrounding its push above $70 per barrel last year finally gets viewed as a major top. Among the catalysts I see for this outcome:
* lower growth in the demand for oil in emerging-market economies
* an explosion in alternatives
* rising spare production capacity
* increasing global refining capacity
* the complete debunking of the hugely flawed "peak oil" theory
* a firmer U.S. dollar
* less demand for gas-guzzling vehicles
* accelerating non-OPEC production
* a reversal of the "contango" in the futures market
* a smaller risk premium
* essentially full global storage
* downside speculation by investment funds
I also expect oil to test $20 to $25 per barrel within the next three years.
17. The situation in the Middle East will "beat" very low expectations as Iran, with the government under fire due to rapidly deteriorating economic conditions, makes some concessions regarding its nuclear program and as the violence in Iraq actually lessens to some extent in the second half of the year.
18. The hugely positive effects from the meaningful decline in energy prices will continue to assert themselves throughout the U.S. economy and stock market.
19. Natural gas will break below last September's low of $4.05 per million BTU as absolute levels in storage hit an all-time high and liquefied natural gas imports into the U.S. surge over 30%.
20. Gold will break below $550 per ounce as demand continues to languish, inflation decelerates further, the U.S. dollar stabilizes and even rises, and investment-fund speculation subsides.
21. Copper will fall below $2 per pound as demand from emerging-market economies slows, investment-fund downside speculation rises, U.S. demand remains subdued as homebuilders work down inventories, and production rises.
22. Growth in China will slow more than estimated as government policies aimed at putting the brakes on investment finally take hold and many large construction projects are completed in preparation for the 2008 Olympics.
23. Emerging stock markets will underperform developed markets as the ending of the mania for commodities slows emerging-market economies. I am keeping a close eye on the Vietnam Stock Index (VNINDEX on Bloomberg), which recently has dwarfed the Nasdaq's meteoric rise in the late 1990s, rocketing 232.4% higher over the last 12 months. It's already 38.5% higher this year. The bursting of this bubble in Vietnam, which I suspect will begin very soon, may well signal the end of the mania for emerging-market stocks.
24. U.S. stocks will see increasing demand, specifically from the public and international investors, as the manias for commodities, emerging markets and low/negative correlation U.S. stock strategies reverse course.
25. Similar to No. 8, investors' irrational pessimism will lift. The 50-week moving average of the American Association of Individual Investors investor survey's level of bears, which is currently at very high levels seen only two other times since tracking began in the 1980s, will move back to levels normally associated with strong bull markets. After hitting new all-time records during the first half of the year, short interest on the NYSE and Nasdaq finally will show meaningful declines in the second half of the year, as some bears finally capitulate and investment funds that benefit from a declining or stagnant U.S. stock market begin to see meaningful redemptions. The percentage of U.S. mutual fund assets in domestic stocks is at the lowest since at least 1984, when record-keeping began. U.S. stock mutual funds, which have seen outflows for almost all of the last year, finally will see meaningful inflows.
26. A low supply of U.S. stocks and increasing demand will make for a lethally bullish combination.
27. Merger and acquisition activity will remain robust. Private-equity buying power currently is projected to be around $1.5 trillion, and S&P 500 companies are flush with $609.6 billion in cash, double the amount they had in 1999.
28. The supply of U.S. stock will remain low. The total value of U.S. shares contracted in 2006, despite stocks' rising prices, by the greatest amount in 22 years as a result of booming M&A, giant corporate stock buybacks, muted IPO activity and limited secondary offerings. I expect more of the same in 2007.
29. Options backdating scandals will subside, and investors finally will begin to view U.S. stocks' balance sheets as the cleanest and most transparent in the world.
30. The belief by many that the U.S. is still in a secular bear market will completely fade as the S&P 500 breaks out to an all-time high, joining the DJIA and Russell 2000.
31. The price-to-earnings ratio on the S&P 500 will rise to 18.1 by year-end. Despite a 92.0% total return (which is equivalent to a 16.3% average annual return) for the S&P 500 since the October 2002 bottom, its forward P/E has contracted relentlessly and now stands at a very reasonable 15.6. The 20-year average P/E for the S&P 500 is 23.0. The S&P 500's P/E multiple has contracted for three consecutive years. It has contracted for four consecutive years only twice since 1905. Each point of multiple expansion is equivalent to a 6.6% gain in the S&P 500.
32. "Growth" stocks will lead the broad market higher, with the Russell 1000 iShares rising a total of 25%. On a price-to-cash flow basis, "growth" stocks are cheaper than "value" stocks for the first time since at least 1977. Almost the entire decline in the S&P 500's P/E since the bubble burst in 2000 can be attributed to multiple contraction in growth stocks. Technology, telecom, retail, biotech, medical, health care, Internet banking, restaurant, gaming and airline shares are likely to be the top performers.
HTI correction- 3,500,000 share buy at 7.70- $27 million buy!
HTI just had a $3.5 million block buy at 7.70!!! Now up to 8.15- something big is coming
HTI up 13% now but on low volume.
HTI running a little bit here. Needs more volume though! Following up on its $100 Million + news with Roche last month.
HTI has some great news this morning.
Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic.
"The findings from this first clinical trial of Enhanze Technology provide proof of concept that rHuPH20 may also have clinical application for large molecule therapeutics," said Richard C. Yocum, MD, Vice President of Clinical Development and Medical Affairs at Halozyme. "Additional studies with larger patient sample sizes are warranted to further characterize the rHuPH20 effect, especially with regard to optimal dose, and to investigate the role that rHuPH20 may play in addressing unmet needs in the administration of large molecule agents, thereby opening up new areas of therapeutic indications."
HTI @ 8.54. Watch L2 on this- trades really nice. I swear it's trading like more huge news on the way. Had huge news on DEC 5 with one of Europe's largest Pharms- worth over $111 million with incentives for up to 1/2 a billion!
Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug Delivery
Dec 5, 2006 5:48:00 PM
BASEL, Switzerland and SAN DIEGO, Dec. 5 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Amex: HTI) and Roche today announced they have entered into an agreement to apply Halozyme's proprietary Enhanze(TM) Technology to Roche's biological therapeutic compounds. Enhanze Technology is Halozyme's proprietary drug delivery technology based on its recombinant human hyaluronidase (rHuPH20). rHuPH20 is an analogue of a human enzyme that temporarily clears space in the matrix of tissues such as skin. This clearing activity should allow rHuPH20 to improve drug delivery by enhancing the entry of therapeutic molecules through the subcutaneous space.
HTI @ 8.40! Volume coming in now.
HTI @ 8.24 from my 7.10 alert. Still looking really good. YOu need to do some DD on this!
HTI- once again I'm a lone voice crying out in the wilderness. HTI is popping today, breaking $8 as I write. Posted on it at 7.10. The chart says that this is not going to stop for a while. Hope some of you can make some coin on this. Very hot right now. Wait for a dip and jump in. THis looks like the second leg of the ACOR move to me. GL
it broke! HTI is going up from here!
HTI!!! going to break 7.50 right now!
WOW!- check out the HTI chart. I've been alerting you guys about it the last couple of days. Looks like today should be the day for a break out. Now just 15 cents from all time high. If it breaks 7.50 it's going to blow. Volume picked up dramatically yesterday as well. I'm hoping in a week or so this around $15 - $18 especially with any news. RADAR IT!
put HTI on your radar- the chart is looking GREAT! Ready to break out...
HTI- ready to POP here it looks like. If this breaks 7.50 watch out. This play is looking really good here. Volume picking up today and tested 7.46 already. Do your DD on this one- you're going to like what you find out. I'm looking for 10-11 this week on the next break.
I really hope you guys are watching HTI this week. Ever since hitting an all time high of 7.50 5 days ago on contract news with Roche (one of the largest Pharms in Europe) this POS has been trading within 6% of that all time high. That's extremely bullish and I really feel that this on the brink of another huge surge upward this week.
GM! HTI is looking to break its alltime high again either today or tomorrow. There's some resistence at 7.10 and then hopefully the break at 7.50. THis is going to be huge once it breaks that high. Definitely keep this on your radar! GLA!
HTI showing some strength here, watch and see if it starts inching above 7 again. If it does it could really take off. Down only 1.5% today on low volume. Keep it on your radar@!
Maybe HTI is in the middle of an ACOR type move. What do you think?
HTI taking off like I said. 7.50!
Hello HTI hourly chart! You're looking fine today...